De-Novo Acute Myeloid Leukemia with Trilineage Myelodysplasia (AML/TMDS) and Myelodysplastic Remission Marrow (AML/MRM)

References

• Bennett J. M., Catovsky D., Daniel M. T., et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Galton D. A. G. The myelodysplastic syndromes. Clin. Lab. Haematol. 1984; 6: 99–112
   PubMedGoogle Scholar
• Brito-Babapulle F., Catovsky D., Galton D. A. G. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. Br. J. Haematol. 1987; 66: 445–450
   PubMed Web of Science ®Google Scholar
• Gajewski J. L., Ho W. G., Nimer S. D., et al. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome. J. Clin. Oncol. 1989; 7: 1637–1645
   PubMed Web of Science ®Google Scholar
• Estienne M. H., Fenaux P., Preudhomme C., et al. Prognostic value of dysmyelopoietic features in de novo acute myeloid leukemia: a report on 132 patients. Clin. Lab. Haematol. 1990; 12: 57–65
   PubMedGoogle Scholar
• Kuriyama K., Tomonaga M., Matsuo T., et al. Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Br. J. Haematol. 1994; 86: 767–773
   PubMed Web of Science ®Google Scholar
• De Witte T., Muus P., De Pauw B., Haanen C. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer 1990; 66: 831–837
   PubMed Web of Science ®Google Scholar
• Fenaux P., Morel P., Rose C., Lai J. L., Jouet J. P., Bauters F. Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy. Br. J. Haematol. 1991; 77: 497–501
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle F., Catovsky D., Galton D. A. G. Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation. Br. J. Haematol. 1988; 68: 411–415
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Singer J. W., Raskind W. H., et al. Clonal development, stem cell differentiation and the nature of clinical remissions in acute nonlymphocytic leukemia: studies of patients heterozygous for glucose-6-phosphate dehydrogenase. N. Engl. J. Med. 1987; 317: 468–473
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Singer J. W., Raskind W. H., et al. Clonal remissions in acute nonlymphocytic leukemia; evidence for a multistep pathogenesis of the malignancy. Blood 1987; 77: 1415–1417
   Google Scholar
• Foucar K., Vaughan W. P., Patil J. O., Armitage S., Dick F., Karp J. E. Postleukemic dysmyelopoiesis. Am. J. Hematol. 1983; 15: 321–334
   PubMed Web of Science ®Google Scholar
• Layton D. M., Mufti R. M., Ireland G. J., Bellingham A. J. Myelodysplastic relapse of de-novo AML: a heterogeneous entity?. Leuk. Res. 1987; 11: 1055–1056
   PubMed Web of Science ®Google Scholar
• Steed A. J., Geary C. G. Post-leukemic myelodysplasia: does it exist? (abstract). Br. J. Haematol. 1987; 66: 419
   Web of Science ®Google Scholar
• Nagai K., Matsuo T., Atogami S., et al. Remission with morphological myelodysplasia in de novo acute myeloid leukaemia: implications for early relapse. Br. J. Haematol. 1992; 81: 33–39
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., et al. Proposals for the classification of the acute leukamias. Br. J. Haematol. 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Gold E. J., Conjalka M., Pelus L. M., et al. Marrow cytogenetic and cell culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis. J. Clin. Oncol. 1983; 1: 627–634
   PubMed Web of Science ®Google Scholar
• Knapp R. H., Dewald G. W., Pierre R. V. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clin. Proc 1985; 60: 507–516
   PubMed Web of Science ®Google Scholar
• Maserati E., Casali M., Pasquali F., et al. Translocation (8;21) in two cases of refractory anemia with excess of blasts in transformation. Cancer Genet. Cytogenet. 1992; 58: 76–78
   PubMed Web of Science ®Google Scholar
• Ferro M. T., Steegman J. L., Escribano L., et al. Ph-positive chronic myeloid leukemia with t(8;21)(q22;q22) in blastic crisis. Cancer Genet. Cytogenet. 1992; 58: 96–99
   PubMed Web of Science ®Google Scholar
• Kwong Y. L., Ching L. M., Liu H. W., Lee C. P., Pollock A., Chan L. C. 8;21 Translocation and mul-tilineage involvement. Am. J. Hematol. 1993; 43: 212–216
   PubMed Web of Science ®Google Scholar
• Tamura S., Kanamaru A., Kakishita E., Nagai K. Detection of latent subclones with abnormal karyotypes by long-term bone marrow cultures in cases of myelodysplastic syndrome. Br. J. Haematol. 1992; 81: 353–361
   PubMed Web of Science ®Google Scholar
• Tamura S., Kanamaru A., Takemoto Y., Kakishita E., Nagai K. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow. Br. J. Haematol. 1993; 84: 219–226
   PubMed Web of Science ®Google Scholar
• Heim S., Sørensen A.-G., Christensen B. E., Pedersen N. T. Re-emergence in remission of primary clone in acute myelogenous leukaemias with multiple chromosomal aberrations at diagnosis. Br. J. Haematol. 1992; 82: 332–336
   PubMed Web of Science ®Google Scholar
• Appelbaum F. R., Dahlberg S., Thomas E. D., et al. Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. Ann. Int. Med. 1984; 101: 581–588
   PubMed Web of Science ®Google Scholar
• Rohatiner A. Z. S., Gregory W. M., Bassen R., et al. Short-term therapy for acute myelogenous leukemia. J. Clin. Oncol. 1988; 6: 218–226
   PubMed Web of Science ®Google Scholar
• Nowel P. C. The clonal evolution of tumor cell populations. Acquired genetic lability permits step-wise selection of variant sublines and underlies tumor progression. Science 1976; 194: 23–28
   PubMed Web of Science ®Google Scholar
• Geddes A. D., Bowen D. T., Jacobs A. Clonal karyotype abnormalities and clonal progress in the myelodysplastic syndrome. Br. J. Haematol. 1990; 76: 194–202
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Secondary chromosome aberrations in the acute leukemias. Cancer Genet. Cytogenet. 1986; 22: 331–338
   PubMed Web of Science ®Google Scholar
• Krulik M., Smadja N., De Gramont A., et al. Sequential karyotype study on Ph-positive chronic myelocytic leukemia. Significance of additional chromosomal abnormalities during disease evolution. Cancer 1978; 60: 974–979
   Web of Science ®Google Scholar
• Lipschitz D. A., Udupa K. B., Milton K. Y., Thompson C. O. Effect of age on hematopoiesis in man. Blood 1984; 63: 502–509
   PubMed Web of Science ®Google Scholar
• Jowitt S. N., Liu Yiu J. A., Saunders M. J., Lucas G. S. Clonal remissions in acute myeloid leukaemia are commonly associated with features of trilineage myelodysplasia during remission. Br. J. Haematol. 1993; 85: 698–705
   PubMed Web of Science ®Google Scholar
• Biggs J. C., Horowitz M. M., Gale R. P., et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 1992; 80: 1090–1093
   PubMed Web of Science ®Google Scholar